Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
disease | 1.000 | definitive | 0.981 | 17 | 6 | 2001 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.990 | None | 1.000 | 17 | 31 | 1989 | 2018 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 0.720 | definitive | 1.000 | 17 | 10 | 1995 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.900 | definitive | 0.974 | 17 | 0 | 2001 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.700 | moderate | 1.000 | 17 | 14 | 2000 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.660 | None | 0.970 | 17 | 46 | 2001 | 2018 | ||||||||
|
collagen type I alpha 2 chain | 0.486 | 0.846 | 1.00 |
|
disease | 0.660 | strong | 1.000 | 16 | 29 | 1985 | 2011 | ||||||||
|
collagen type I alpha 2 chain | 0.486 | 0.846 | 1.00 |
|
disease | 0.950 | strong | 1.000 | 16 | 34 | 1991 | 2018 | ||||||||
|
NIPBL cohesin loading factor | 0.521 | 0.808 | 1.00 |
|
disease | 0.700 | strong | 1.000 | 16 | 263 | 1993 | 2019 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
disease | 0.900 | definitive | 0.979 | 16 | 1 | 1988 | 2020 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 1.000 | None | 0.982 | 16 | 22 | 1995 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 16 | 45 | 1994 | 2011 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.720 | None | 1.000 | 16 | 52 | 2002 | 2017 | ||||||||
|
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | 0.534 | 0.769 | 1.00 |
|
disease | 0.300 | definitive | 1.000 | 15 | 0 | 2008 | 2017 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 1.000 | None | 0.976 | 15 | 191 | 1988 | 2019 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.986 | 15 | 155 | 1984 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.989 | 15 | 35 | 1990 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.600 | definitive | 0.983 | 15 | 0 | 2000 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.800 | None | 0.966 | 15 | 21 | 1996 | 2018 | ||||||||
|
SH3 and multiple ankyrin repeat domains 3 | 0.550 | 0.731 | 1.00 |
|
disease | 1.000 | definitive | 1.000 | 15 | 9 | 2001 | 2020 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
disease | 1.000 | definitive | 0.984 | 14 | 10 | 1998 | 2019 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
group | 0.900 | definitive | 0.976 | 14 | 23 | 1990 | 2019 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 1.000 | definitive | 0.980 | 14 | 16 | 1994 | 2020 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 1.000 | None | 1.000 | 13 | 12 | 1988 | 2012 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
disease | 0.800 | strong | 0.971 | 13 | 29 | 1984 | 2020 |